Resistance training-induced muscle hypertrophy is mediated by TGF-β1-Smad signaling pathway in male Wistar rats

J Cell Physiol. 2020 Jul;235(7-8):5649-5665. doi: 10.1002/jcp.29497. Epub 2020 Jan 21.

Abstract

The TGF-β1-Smad pathway is a well-known negative regulator of muscle growth; however, its potential role in resistance training-induced muscle hypertrophy is not clear. The present study proposed to determine whether and how this pathway may be involved in resistance training-induced muscle hypertrophy. Skeletal muscle samples were collected from the control, trained (RT), control + SB431542 (CITGF ), and trained + SB431542 (RTITGF ) animals following 3, 5, and 8 weeks of resistance training. Inhibition of the TGF-β1-Smad pathway by SB431542 augmented muscle satellite cells activation, upregulated Akt/mTOR/S6K1 pathway, and attenuated FOXO1 and FOXO3a expression in the CITGF group (all p < .01), thereby causing significant muscle hypertrophy in animals from the CITGF . Resistance training significantly decreased muscle TGF-β1 expression and Smad3 (P-Smad3S423/425 ) phosphorylation at COOH-terminal residues, augmented Smad2 (P-Smad2-LS245/250/255 ) and Smad3 (P-Smad3-LSer208 ) phosphorylation levels at linker sites (all p < .01), and led to a muscle hypertrophy which was unaffected by SB431542, suggesting that the TGF-β1-Smad signaling pathway is involved in resistance training-induced muscle hypertrophy. The effects of inhibiting the TGF-β1-Smad signaling pathway were not additive to the resistance training effects on FOXO1 and FOXO3a expression, muscle satellite cells activation, and the Akt/mTOR/S6K1 pathway. Resistance training effect of satellite cell differentiation was independent of the TGF-β1-Smad signaling pathway. These results suggested that the effect of the TGF-β1-Smad signaling pathway on resistance training-induced muscle hypertrophy can be attributed mainly to its diminished inhibitory effects on satellite cell activation and protein synthesis. Suppressed P-Smad3S423/425 and enhanced P-Smad2-LS245/250/255 and P-Smad3-LSer208 are the molecular mechanisms that link the TGF-β1-Smad signaling pathway to resistance training-induced muscle hypertrophy.

Keywords: TGF-β1-Smad signaling pathway; muscle hypertrophy; resistance training; transforming growth factor β1.

MeSH terms

  • Animals
  • Benzamides / pharmacology
  • Cell Differentiation / drug effects
  • Dioxoles / pharmacology
  • Disease Models, Animal
  • Humans
  • Hypertrophy / genetics*
  • Hypertrophy / physiopathology
  • Male
  • Muscles / drug effects
  • Muscular Diseases / genetics*
  • Muscular Diseases / physiopathology
  • Phosphorylation / drug effects
  • Rats
  • Rats, Wistar
  • Resistance Training / adverse effects*
  • Signal Transduction / drug effects
  • Signal Transduction / genetics
  • Smad2 Protein / genetics*
  • Smad3 Protein / genetics*
  • Transforming Growth Factor beta1 / genetics*

Substances

  • 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide
  • Benzamides
  • Dioxoles
  • Smad2 Protein
  • Smad2 protein, rat
  • Smad3 Protein
  • Smad3 protein, rat
  • Tgfb1 protein, rat
  • Transforming Growth Factor beta1

Supplementary concepts

  • Myostatin-related muscle hypertrophy